Company / Cost of Revenue
Personalis, Inc. Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$53.9M
FY2025
5-year range
$51.7M / $55.3M
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
#102 of 113
Health Care
What the data says
Among 113 Health Care companies, Personalis, Inc. is in the top 10% for cost of revenue. Cost of Revenue has fluctuated over the past 9 years, ranging from $12M in FY2019 to $55M in FY2024.
Based on SEC 10-K filings.
$54M in FY2025 with a 5-year CAGR of +15.7%.
Remained stable around $54M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +1.4%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 113This company $53.9M Sector average $11.3B
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.7%, indicating consistent growth.
- In FY2025, cost of revenue decreased 2.5% year-over-year.
- Ranks #102 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $53.9M | -2.5% |
| FY2024 | $55.3M | +2.7% |
| FY2023 | $53.8M | +4.1% |
| FY2022 | $51.7M | -4.0% |
| FY2021 | $53.8M | +107.3% |
| FY2020 | $26.0M | +121.3% |
| FY2019 | $11.7M | -54.8% |
| FY2018 | $26.0M | +121.3% |
| FY2017 | $11.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026